{"schema_version":"1.0","type":"article","title":"川普放政策鴿子，減肥藥價格白降了？","url":"https://drugnews.com.tw/articles/2026-05-10-glp1-medicare-policy-delay.html","markdown_url":"https://drugnews.com.tw/articles/2026-05-10-glp1-medicare-policy-delay.md","lang":"zh-Hant","date":"2026-05-10","publish_at":"2026-05-10T10:30:00+08:00","updated_at":"2026-05-10","category":"商業分析系列","topic":"商業分析系列","tags":["Dcard","免費文章","Alzheimer","GLP-1","Tirzepatide","FDA","減重藥"],"summary":"【川普政府放了 Eli Lilly（禮來）、Novo Nordisk （諾和諾德）的「鴿子」？GLP-1 進 Medicare，為什麼臨門一腳又卡住了】📌 2026 年 4 月下旬，美國減重藥市場出現","key_points":[],"facts":[],"sections":["01｜政策破冰，但沒有真正解凍","02｜保險公司為什麼猶豫？因為 GLP-1 是一個「用量不可預測」的財務黑洞","03｜CMS 沒有完全撤退，而是改用 Bridge 撐住過渡期","04｜Eli Lilly 與 Novo Nordisk 最尷尬：價格先讓了，需求端卻沒有完全打開","05｜這件事真正揭露的是：GLP-1 正在從「藥效故事」進入「支付戰爭」","06｜立法問題終究繞不過去"],"references":[{"title":"[0]: 各公司官網＆公開資料","source":"","date":"","url":""},{"title":"[1]:","source":"","date":"","url":""},{"title":"BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model","source":"CMS","date":"","url":""},{"title":"The BALANCE Model aims to increase access to select GLP-1 medications and healthy lifestyle interventions — to help people with Medicare and Medicaid improve their health.","source":"","date":"","url":""},{"title":"www.cms.gov","source":"","date":"","url":""},{"title":"\"BALANCE (Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth) Model","source":"CMS\"","date":"","url":""},{"title":"[2]:","source":"","date":"","url":""},{"title":"reuters.com","source":"","date":"","url":""},{"title":"https://www.reuters.com/business/healthcare-pharmaceuticals/us-health-agency-expand-access-glp-1-weight-loss-drugs-2025-12-23/","source":"","date":"","url":"https://www.reuters.com/business/healthcare-pharmaceuticals/us-health-agency-expand-access-glp-1-weight-loss-drugs-2025-12-23/"},{"title":"www.reuters.com","source":"","date":"","url":""},{"title":"\"US health agency unveils weight-loss drug coverage model","source":"Reuters\"","date":"","url":""},{"title":"[3]:","source":"","date":"","url":""},{"title":"reuters.com","source":"","date":"","url":""},{"title":"https://www.reuters.com/legal/litigation/delay-medicare-pilot-obesity-drugs-may-not-hurt-near-term-demand-analysts-say-2026-04-22/","source":"","date":"","url":"https://www.reuters.com/legal/litigation/delay-medicare-pilot-obesity-drugs-may-not-hurt-near-term-demand-analysts-say-2026-04-22/"},{"title":"www.reuters.com","source":"","date":"","url":""},{"title":"\"Delay in Medicare pilot for obesity drugs may not hurt near-term demand, analysts say","source":"Reuters\"","date":"","url":""},{"title":"[4]:","source":"","date":"","url":""},{"title":"CMS Extends Medicare’s Short-Term Bridge Program for GLP-1 Obesity Drug Coverage","source":"KFF Quick Takes","date":"","url":""},{"title":"Extending the short-term GLP-1 Bridge program is good news for eligible Medicare beneficiaries because it provides the certainty of obesity drug coverage at a $50 copay for a longer duration, but federal spending will also rise by some unknown amount sinc","source":"","date":"","url":""},{"title":"www.kff.org","source":"","date":"","url":""},{"title":"\"CMS Extends Medicare’s Short-Term Bridge Program for GLP-1 Obesity Drug Coverage","source":"KFF Quick Takes\"","date":"","url":""}],"images":[{"alt":"Dcard 原圖：川普放政策鴿子，減肥藥價格白降了？","url":"https://drugnews.com.tw/assets/articles/glp1-medicare-policy-delay/dcard-01.webp"},{"alt":"Dcard 原圖：川普放政策鴿子，減肥藥價格白降了？","url":"https://drugnews.com.tw/assets/articles/glp1-medicare-policy-delay/dcard-02.webp"},{"alt":"Dcard 原圖：川普放政策鴿子，減肥藥價格白降了？","url":"https://drugnews.com.tw/assets/articles/glp1-medicare-policy-delay/dcard-03.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/glp1-medicare-policy-delay/dcard-01.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-05-10）。川普放政策鴿子，減肥藥價格白降了？。https://drugnews.com.tw/articles/2026-05-10-glp1-medicare-policy-delay.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-05-10-glp1-medicare-policy-delay-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}